IntelliGenes, a first of its kind software created at Rutgers Health, combines artificial intelligence (AI) and machine-learning approaches to measure the significance of specific genomic biomarkers to help predict diseases…

This content originally appeared on diaTribe. Republished with permission.By Amelia Harnish Feeling shaky, tired, and irritable after a nighttime low? For people with diabetes, this phenomenon is known as a “low…

A new study at the University of Missouri's Thompson Center for Autism and Neurodevelopment found that propranolol, a medication that treats high blood pressure, can also help lower anxiety for…

Ozempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes and chronic liver disease, according to a…

A combination therapy with multiple drugs is more effective than just one active compound. To begin with, at least.

Vadim Jucaud, Ph.D., Assistant Professor at the Terasaki Institute for Biomedical Innovation, has been awarded a grant from the National Institutes of Health to develop a functional organ-on-a-chip to model…

One of the things that makes developing effective treatments for Parkinson's disease so challenging is its complexity.

Previous research has established that childhood experience with abuse, neglect, and substance use in the home can worsen a person's heart health throughout their life.

Over the last 20 years, researchers in biology and medicine have created Boolean network models to simulate complex systems and find solutions, including new treatments for colorectal cancer.

A novel rabbit infection model to investigate meropenem's resistance development.